Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 2, 2007, Pages 178-188

  Jormalainen, M ^a,e   Vento, A E ^a   Wartiovaara Kautto, U ^a   Suojaranta Ylinen, R ^a   Lauronen, J ^a,b   Paavonen, T ^c   Petaja J ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d JORVI HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antithrombin; Coagulation; Inflammation; Ischemia; Reperfusion

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III; HEPARIN; MYELOPEROXIDASE; PLACEBO; PLEGISOL; THROMBIN ANTITHROMBIN COMPLEX; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMIC PARAMETERS; HISTOLOGY; LUNG ARTERY PRESSURE; LUNG BIOPSY; LUNG VASCULAR RESISTANCE; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PULMONARY HYPERTENSION; SWINE; SYSTEMIC VASCULAR RESISTANCE; TREATMENT RESPONSE;

ANIMALS; ANTITHROMBINS; BIOPSY; BLOOD COAGULATION; BLOOD GAS ANALYSIS; CARDIOPULMONARY BYPASS; FEMALE; HYPERTENSION, PULMONARY; MALE; MYOCARDIUM; RANDOM ALLOCATION; REPERFUSION INJURY; SUS SCROFA;

EID: 33846410262     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01185.x     Document Type: Article

References (35)

1. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. The systemic inflammatory response. Ann Thorac Surg 1997; 64: S31-7.
2. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T et al. Systemic inflammatory response after cardiac operations. Ann Thorac Surg 1996; 61: 1714-20.
3. Czerny M, Baumer H, Kilo J, Lassnigg A, Hamwi A, Vukovich T et al. Inflammatory response and myocardial injury following coronary artery bypass grafting with and without cardiopulmonary bypass. Eur J Cardiothorac Surg 2000; 17: 727-42.
4. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 2002; 121: 1269-77.
5. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulic TJ. Use of inhaled nitric oxide and acethylcholine in the evaluation of pulmonary artery hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 447-53.
6. Wan S, LeClerc J-L, Vincent J-L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 76-92.
7. Carteaux J-P, Roux S, Siaghy M, Schjöth B, Dolofon P, Bechamps Y et al. Acute pulmonary hypertension after cardiopulmonary bypass in pig: the role of endogenous endothelin. Eur J Cardiothorac Surg 1999; 15: 346-52.
8. Fortier S, Demaria RG, Lamarche Y, Malo O, Denault A, Desjardins F et al. Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction vie increased cyclic adenosine monophosphate levels. J Thorac Cardiovasc Surg 2004; 128: 109-16.
9. Boyle EM Jr, Pohlman TH, Cornejo CJ, Verrier ED. Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. Ann Thorac Surg 1996; 62: 1868-75.
10. Park JL, Lucchesi BL. Mechanisms of myocardial reperfusion injury: Pathophysiology of ischemic reperfusion injury. Ann Thorac Surg 1999; 68: 1905-12.
11. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 2001; 71: 226-32.
12. Esmon CT. Introduction: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 2000; 95: 1113-6.
13. Esmon CT, Taylor FB, Snow TR. Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66: 160-5.
14. Chong AJ, Pohlman TH, Hampton CR, Shimamoto A, Mackman N, Verrier ED. Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury. Ann Thorac Surg 2003; 75: S649-55.
15. Jormalainen M, Vento AE, Wartiovaara-Kautto U, Suojaranta-Ylinen R, Rämö O, Petäjä J. Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model. J Thorac Cardiovasc Surg 2004; 128: 189-96.
16. Rosenberg RD. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 1989; 89: 2S-9S.
17. Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989; 163: 1404-11.
18. 1 alpha in rats. Thromb Res 1995; 80: 201-8.
19. Uchiba M, Okajima K, Murakami K. Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res 1998; 89: 233-41.
20. Okano K, Kokodu Y, Okajima K, Hossain MA, Ishimura K, Yachida S et al. Protective effects of antithrombin III supplementation on warm ischemia and reperfusion injury in rat liver. World J Surg 1996; 20: 1069-75.
21. Mizutani A, Okajima K, Uchiba M, Isobe H, Harada N, Mizutani S et al. Antithrombin reduces ischemia/reperfusion induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 2003; 101: 3029-36.
22. Salvatierra A, Guerrero R, Rodrigues M, Alvarez A, Soriano F, Lopez-Pedrera R et al. Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog. Circulation 2001; 104: 2975-86.
23. Özden A, Tetik C, Bilgihan A, Calli N, Bostanci B, Yis Ö et al. Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats. Res Exp Med (Berl) 1999; 198: 237-46.
24. Margreiter J, Mittermayr M, Mair J, Hammere-Lercher A, Kountchev J, Klinger A et al. Influence of antithrombin on ischemia/reperfusion in jury in the isolated blood-free perfused rat heart. Thromb Res 2003; 108: 249-55.
25. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-52.
26. Jormalainen M, Vento AE, Lukkarinen H, Kääpä P, Kytö V, Lauronen J et al. Inhibition of thrombin by r-hirudin attenuates myocardial apoptosis and improves cardiac performance in a porcine model. J Cardiothorac Vasc Anesth (in press).
27. Levy JH, Despotis GJ, Szlam F, Olson P, Meeker D, Weisinger A. Recombinant human transgenic antithrombin in cardiac surgery: a dose finding study. Anesthesiology 2002; 96: 1095-102.
28. Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + F2. Thromb Haemost 1993; 70: 253-8.
29. Boisclair MD, Lane DA, Philippou H, Eshnouf MP, Sheikh S, Hunt B et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350-7.
30. Chandler WL, Velan T, Hughes R, Moncada S, Vane JR. Estimating the rate of thrombin and fibrin generation during cardiopulmonary bypass. Blood 2003; 101: 4355-62.
31. 2) in chloralose anesthetized dogs. Br J Pharmacol 1977; 61: 136-41.
32. Vento AE, Rämö OJ, Pesonen EJ, Griffin JH, Pesonen E, Syrjälä M et al. The effect of nitecapone, a new antioxidant, on myocardial function after aortic cross-clamping in experimental heart ischemia. Int J Angiol 1999; 8: 16-21.
33. Fernández JA, Vento AE, Jormalainen M, De Mudler PA, Gillebert TC et al. Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects. Cardiovasc Drugs Ther 2006; 20: 113-21.
34. De Hert SG, Rodrigus IE, Heanen LR, De Mudler PA, Gillebert TC. Recovery of systolic and diastolic left ventricular function early after cardiopulmonary bypass. Anesthesiology 1996; 85: 1063-75.
35. Fiddian-Greene RG. Assessment of the adequacy of mucosal oxygenation in patients with intraluminally located silicone tonometers. In: Manabe H, Zweifach BW, Messmer K, eds. Microcirculation in circulatory disorders. New York: Springer-Verlag, 1988: 481-7.